Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

How cardiologists can fight back against misinformation

Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation. 

Tripledemic shortages: Walgreens, CVS limit sale of children’s medications

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.

Why hospitals suffered financially in 2022—and a look ahead to 2023

Health Exec caught up with Erik Swanson, senior vice president of data and analytics at Kaufman Hall, to learn more about the underlying trends throughout 2022 and what hospitals are bracing for in 2023.

Thumbnail

AI specialists ink deal with Pfizer to target cardiac amyloidosis

Cardiac amyloidosis can be especially challenging to identify and diagnose, making it a perfect target for advanced AI models.

JACR’s top 5 articles of 2022

The Journal of the American College of Radiology has named five peer-reviewed papers its best of the year.

New discovery could reduce the risk of heart damage among cancer patients

Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?

There has been fear of a small number of patient who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination

COVID-19 vaccines prevented 3M deaths

An estimated 3.2 million excess deaths and 18.5 million hospitalizations have been prevented due to COVID-19 vaccines, the Commonwealth Fund found.

 

Thumbnail

No antithrombotic therapy after TAVR? New research highlights potential benefits

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients.